All lobbying filings

RUBINER STRATEGIES

Lobbying for KELLEY DRYE & WARREN LLP OBO TOBACCO-FREE KIDS ACTION FUND · Law Firm

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Feb 10, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 7

HR 2586
Reentry Act of 2025
HR 1510
Due Process Continuity of Care Act
S 1720
Due Process Continuity of Care Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 2741
PEER Support Act
S 1329
PEER Support Act
S 3522
No Red Tape For Addiction Treatment Act

Lobbying activity 1

Health Issues

Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); PEER Support Act (H.R. 2741 / S. 1329); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (draft legislation in House and Senate); and FY2026 appropriations language related to substance use prevention and treatment.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.